ADISSP

gene
On this page

Also known as FLJ20550

Summary

ADISSP (adipose secreted signaling protein, HGNC:15873) is a protein-coding gene on chromosome 20p13, encoding Adipose-secreted signaling protein (Q9GZN8). Adipocyte-secreted protein (adipokine) that acts as a key regulator for white adipose tissue (WAT) thermogenesis and glucose homeostasis at least in part through activation of protein kinase A (PKA).

Enables protein phosphatase 1 binding activity. Involved in positive regulation of non-canonical NF-kappaB signal transduction and positive regulation of transforming growth factor beta receptor signaling pathway. Predicted to be located in extracellular space.

Source: NCBI Gene 54976 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 11 total — 1 pathogenic
  • MANE Select transcript: NM_001258429

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15873
Approved symbolADISSP
Nameadipose secreted signaling protein
Location20p13
Locus typegene with protein product
StatusApproved
AliasesFLJ20550
Ensembl geneENSG00000101220
Ensembl biotypeprotein_coding
OMIM620373
Entrez54976

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 15 protein_coding

ENST00000217195, ENST00000379772, ENST00000399672, ENST00000399683, ENST00000888333, ENST00000888334, ENST00000888335, ENST00000888336, ENST00000888337, ENST00000936143, ENST00000936144, ENST00000936145, ENST00000936146, ENST00000936147, ENST00000948129

RefSeq mRNA: 3 — MANE Select: NM_001258429 NM_001039140, NM_001258429, NM_001258430

CCDS: CCDS33436, CCDS58763

Canonical transcript exons

ENST00000379772 — 6 exons

ExonStartEnd
ENSE0000065789937543973754519
ENSE0000148240137600823760186
ENSE0000181424437676633767753
ENSE0000299452737585363758678
ENSE0000315240837554693755607
ENSE0000390310937535083754158

Expression profiles

Bgee: expression breadth ubiquitous, 261 present calls, max score 98.45.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 53.7162 / max 3421.2063, expressed in 1821 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
18616750.45501821
1861682.96141447
1861660.2997116

Top tissues by expression

277 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
nucleus accumbensUBERON:000188298.45gold quality
caudate nucleusUBERON:000187398.07gold quality
putamenUBERON:000187497.56gold quality
muscle layer of sigmoid colonUBERON:003580596.95gold quality
granulocyteCL:000009496.36gold quality
right ovaryUBERON:000211895.72gold quality
left uterine tubeUBERON:000130395.59gold quality
lower esophagus muscularis layerUBERON:003583395.28gold quality
esophagogastric junction muscularis propriaUBERON:003584195.26gold quality
lower esophagusUBERON:001347395.25gold quality
left ovaryUBERON:000211995.01gold quality
deciduaUBERON:000245094.18gold quality
monocyteCL:000057694.14gold quality
leukocyteCL:000073894.05gold quality
mononuclear cellCL:000084294.05gold quality
anterior cingulate cortexUBERON:000983593.70gold quality
cingulate cortexUBERON:000302793.63gold quality
omental fat padUBERON:001041493.51gold quality
peritoneumUBERON:000235893.45gold quality
adipose tissue of abdominal regionUBERON:000780893.21gold quality
body of uterusUBERON:000985393.14gold quality
right frontal lobeUBERON:000281092.82gold quality
subcutaneous adipose tissueUBERON:000219092.77gold quality
right uterine tubeUBERON:000130292.65gold quality
stromal cell of endometriumCL:000225592.12gold quality
prefrontal cortexUBERON:000045192.04gold quality
amygdalaUBERON:000187691.92gold quality
apex of heartUBERON:000209891.79gold quality
hypothalamusUBERON:000189891.70gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.69gold quality

Single-cell (SCXA)

Detected in 8 experiment(s), a significant marker in 8.

ExperimentMarker?Max mean expression
E-MTAB-6701yes131.17
E-MTAB-10287yes100.67
E-MTAB-6678yes26.73
E-CURD-122yes10.88
E-CURD-112yes10.31
E-CURD-88yes8.96
E-MTAB-9801yes7.96
E-ANND-3yes7.16

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

42 targeting ADISSP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-605-3P99.8869.221833
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349
HSA-MIR-548Z99.8470.804349
HSA-MIR-7856-5P99.7569.992901
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-371499.7170.742671
HSA-MIR-612699.6268.09996
HSA-MIR-4708-3P99.5167.99870
HSA-MIR-486-3P99.5166.821901
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-4667-3P99.2665.451608
HSA-MIR-324-3P99.2666.311034
HSA-MIR-465199.0667.572002
HSA-MIR-60898.9367.832013
HSA-MIR-181A-2-3P98.9167.601168

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioADISSPENSDARG00000076239
danio_rerioadisspENSDARG00000087426
mus_musculusAdisspENSMUSG00000027327
rattus_norvegicusAdisspENSRNOG00000021245
drosophila_melanogasterCG6983FBGN0035896

Protein

Protein identifiers

Adipose-secreted signaling proteinQ9GZN8 (reviewed: Q9GZN8)

All UniProt accessions (2): Q9GZN8, H7BYU9

UniProt curated annotations — full annotation on UniProt →

Function. Adipocyte-secreted protein (adipokine) that acts as a key regulator for white adipose tissue (WAT) thermogenesis and glucose homeostasis at least in part through activation of protein kinase A (PKA).

Subcellular location. Secreted.

Similarity. Belongs to the ADISSP family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9GZN8-11yes
Q9GZN8-22

RefSeq proteins (3): NP_001034229, NP_001245358, NP_001245359 (=MANE)

Domains & families (InterPro)

IDNameType
IPR026794ADISSPFamily

Pfam: PF15006

UniProt features (6 total): modified residue 2, initiator methionine 1, chain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9GZN8-F180.450.49

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 2, 147

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 150 (showing top): RNGTGGGC_UNKNOWN, VERHAAK_AML_WITH_NPM1_MUTATED_DN, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, CMYB_01, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION

GO Biological Process (5): obsolete positive regulation of protein kinase A signaling (GO:0010739), positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511), glucose homeostasis (GO:0042593), positive regulation of non-canonical NF-kappaB signal transduction (GO:1901224), adaptive thermogenesis (GO:1990845)

GO Molecular Function (1): protein phosphatase 1 binding (GO:0008157)

GO Cellular Component (3): obsolete extracellular space (GO:0005615), cellular_component (GO:0005575), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transforming growth factor beta receptor signaling pathway1
regulation of transforming growth factor beta receptor signaling pathway1
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway1
positive regulation of cellular response to transforming growth factor beta stimulus1
carbohydrate homeostasis1
non-canonical NF-kappaB signal transduction1
regulation of non-canonical NF-kappaB signal transduction1
positive regulation of intracellular signal transduction1
temperature homeostasis1
protein phosphatase binding1
cellular anatomical structure1

Protein interactions and networks

STRING

414 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ADISSPDMWDQ09019627
ADISSPSEC24CP53992595
ADISSPBRK1Q8WUW1594
ADISSPHIP1RO75146577
ADISSPJCADQ9P266552
ADISSPSWAP70Q9UH65548
ADISSPCPNE1Q99829528
ADISSPTOR4AQ9NXH8518
ADISSPPCYT2Q99447513
ADISSPTPM3P06753474
ADISSPATG3Q9NT62441
ADISSPPSME3P61289376
ADISSPQSER1Q2KHR3376
ADISSPHEBP1Q9NRV9370
ADISSPATAD3BQ5T9A4357

IntAct

25 interactions, top by confidence:

ABTypeScore
PPP1CAPPP1CCpsi-mi:“MI:0914”(association)0.850
PPP1CBCCDC85Cpsi-mi:“MI:0914”(association)0.750
PPP1CCCCDC85Cpsi-mi:“MI:0914”(association)0.740
PPP1CACCDC85Cpsi-mi:“MI:0914”(association)0.670
PPP1CAPQBP1psi-mi:“MI:0914”(association)0.510
PPP1R7CCDC85Cpsi-mi:“MI:0914”(association)0.510
ADISSPreppsi-mi:“MI:0915”(physical association)0.370
PHKBADISSPpsi-mi:“MI:0915”(physical association)0.370
ADISSPRALYLpsi-mi:“MI:0915”(physical association)0.370
PPP1CCRPLP2psi-mi:“MI:0914”(association)0.350
PPP1CACCDC85Cpsi-mi:“MI:0914”(association)0.350
FAM133ADNM1Lpsi-mi:“MI:0914”(association)0.350
EPB41L5LIN7Apsi-mi:“MI:0914”(association)0.350
TMEM69ACOX3psi-mi:“MI:0914”(association)0.350
ARHGEF7ACOX3psi-mi:“MI:0914”(association)0.350
PCDHGA9UBA6psi-mi:“MI:0914”(association)0.350
PPP1CCPLEKHG3psi-mi:“MI:0914”(association)0.350
PPP1CAADISSPpsi-mi:“MI:0915”(physical association)0.000
PPP1CBADISSPpsi-mi:“MI:0915”(physical association)0.000
PPP1R7ADISSPpsi-mi:“MI:0915”(physical association)0.000
FERMT2ADISSPpsi-mi:“MI:0915”(physical association)0.000

BioGRID (49): C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Two-hybrid), RALYL (Two-hybrid), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS), C20orf27 (Affinity Capture-MS)

ESM2 similar proteins: A6QLH6, B0KWT6, B1MTV8, B2GV38, B2KIK3, B5X9S9, B5XFI8, B7NZQ9, C1BGZ8, C9J798, O09172, O14908, O43374, O70422, P0CL18, P11441, P21126, P41214, P48507, P48508, P60027, Q0P5I8, Q2T9Y6, Q2TBN5, Q32LP0, Q3B7U9, Q58CR3, Q5R4T1, Q5R812, Q5RA63, Q5RB75, Q5RCR8, Q5ZMQ0, Q66H91, Q68FF6, Q7ZWB2, Q8BPA8, Q8IVD9, Q8R1T1, Q8WUX9

Diamond homologs: B5FX50, Q2KIM1, Q4KM45, Q68FA2, Q9D1K7, Q9GZN8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

11 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
3024618GRCh37/hg19 20p13-12.1(chr20:68351-16142323)x3Pathogenic

SpliceAI

1094 predictions. Top by Δscore:

VariantEffectΔscore
20:3754154:CCGGT:Cacceptor_gain1.0000
20:3754155:CGGT:Cacceptor_gain1.0000
20:3754155:CGGTC:Cacceptor_gain1.0000
20:3754156:GGT:Gacceptor_gain1.0000
20:3754156:GGTC:Gacceptor_loss1.0000
20:3754157:GT:Gacceptor_gain1.0000
20:3754157:GTCT:Gacceptor_loss1.0000
20:3754158:TCT:Tacceptor_loss1.0000
20:3754159:C:CCacceptor_gain1.0000
20:3754160:T:Cacceptor_loss1.0000
20:3754324:C:Adonor_gain1.0000
20:3754388:CG:Cdonor_gain1.0000
20:3754516:TAAC:Tacceptor_gain1.0000
20:3754525:C:Tacceptor_gain1.0000
20:3755464:CGCA:Cdonor_loss1.0000
20:3755465:GCACC:Gdonor_loss1.0000
20:3755466:CACCT:Cdonor_loss1.0000
20:3758533:TA:Tdonor_loss1.0000
20:3758534:A:Cdonor_loss1.0000
20:3758535:CCT:Cdonor_gain1.0000
20:3758537:TTG:Tdonor_gain1.0000
20:3758538:TG:Tdonor_gain1.0000
20:3758561:T:Adonor_gain1.0000
20:3758675:TTGC:Tacceptor_gain1.0000
20:3758676:TGC:Tacceptor_gain1.0000
20:3758676:TGCCT:Tacceptor_loss1.0000
20:3758677:GC:Gacceptor_gain1.0000
20:3758678:CC:Cacceptor_gain1.0000
20:3758679:C:CAacceptor_loss1.0000
20:3758679:C:CCacceptor_gain1.0000

AlphaMissense

1148 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:3754140:G:TP148H1.000
20:3755599:G:CF57L1.000
20:3755599:G:TF57L1.000
20:3755600:A:GF57S1.000
20:3755601:A:GF57L1.000
20:3754122:A:TV154D0.999
20:3754141:G:AP148S0.999
20:3754141:G:TP148T0.999
20:3754146:C:TG146D0.999
20:3754402:A:TV140D0.999
20:3755580:A:GY64H0.999
20:3755597:A:GL58P0.999
20:3755597:A:TL58Q0.999
20:3755600:A:CF57C0.999
20:3755601:A:CF57V0.999
20:3755603:C:TG56D0.999
20:3755604:C:GG56R0.999
20:3758540:A:TV53D0.999
20:3758576:A:TV41D0.999
20:3758602:A:CF32L0.999
20:3758602:A:TF32L0.999
20:3758604:A:GF32L0.999
20:3754064:A:CF173L0.998
20:3754064:A:TF173L0.998
20:3754066:A:GF173L0.998
20:3754134:A:GL150P0.998
20:3754134:A:TL150Q0.998
20:3754140:G:CP148R0.998
20:3754146:C:AG146V0.998
20:3754147:C:AG146C0.998

dbSNP variants (sampled 300 via entrez): RS1000211955 (20:3764666 C>T), RS1000267308 (20:3757914 G>A), RS1000416166 (20:3760083 C>T), RS1000752640 (20:3758747 C>G,T), RS1000812809 (20:3753114 C>T), RS1000814833 (20:3764388 A>G), RS1000851654 (20:3765383 G>C), RS1000917430 (20:3765112 G>C), RS1001224735 (20:3756647 G>A), RS1001416511 (20:3761383 T>C), RS1001601261 (20:3768008 G>A), RS1001716844 (20:3756472 G>A), RS1001879886 (20:3759195 C>G,T), RS1001907358 (20:3767029 C>A), RS1001968795 (20:3768175 C>T)

Disease associations

OMIM: gene MIM:620373 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST002822_12Survival in colon cancer7.000000e-06
GCST003075_23Cognitive decline rate in late mild cognitive impairment6.000000e-07
GCST003075_62Cognitive decline rate in late mild cognitive impairment7.000000e-07
GCST004602_228Mean corpuscular volume3.000000e-12
GCST90002392_80Mean corpuscular volume6.000000e-38
GCST90002396_49Mean reticulocyte volume8.000000e-16
GCST90002397_445Mean spheric corpuscular volume7.000000e-39
GCST90002398_52Neutrophil count1.000000e-10
GCST90002403_310Red blood cell count8.000000e-09
GCST90002405_439Reticulocyte count6.000000e-10

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0000409disease free survival
EFO:0007710cognitive decline measurement
EFO:0010701mean reticulocyte volume
EFO:0004833neutrophil count
EFO:0004305erythrocyte count
EFO:0007986reticulocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

34 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, increases methylation3
cobaltous chloridedecreases expression2
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteincreases expression1
zinc chromatedecreases expression, increases abundance1
chromium hexavalent iondecreases expression, increases abundance1
ICG 001increases expression1
jinfukangincreases expression1
NSC 689534affects binding, decreases expression1
(+)-JQ1 compounddecreases expression1
bisphenol AFincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Temozolomideincreases expression1
Acetaminophendecreases expression1
Cadmiumincreases abundance, increases expression1
Calcitrioldecreases expression, affects cotreatment1
Copperaffects binding, decreases expression1
Diazinonincreases methylation1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Ivermectindecreases expression1
Methyl Methanesulfonatedecreases expression1
Seleniumaffects cotreatment, decreases expression1
Silicon Dioxideincreases expression1
Smokedecreases expression1
Testosteronedecreases expression, affects cotreatment1
Thiramdecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Vitamin Eaffects cotreatment, decreases expression, increases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2TAAbcam HEK293T C20orf27 KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): colonic neoplasm